WhatsApp +852 9339 8574
FOXO4 is a synthetically engineered bioactive peptide. Thanks to its unique targeted binding properties, it is widely used in *in vitro* research—spanning areas such as cellular senescence mechanisms, the regulation of cellular homeostasis, and protection against oxidative damage—and is a highly valued reagent in studies involving senescence-related cell models. This peptide specifically binds to intracellular target proteins, disrupts protein-protein interactions, and selectively modulates the survival status of senescent cells; simultaneously, it participates in regulating intracellular gene expression and influences biochemical processes associated with the cell cycle and programmed apoptosis. Unlike broad-spectrum bioactive agents, FOXO4 acts on highly specific targets, avoiding indiscriminate interference with the basic physiological functions of normal cells. Characterized by precise targeting, stable activity, and a mature synthesis process, FOXO4 is extensively utilized in research projects concerning cell biology, cellular aging, and microenvironment regulation, maintaining steady demand and significant utility in the market for peptide research reagents.
The defining characteristic of FOXO4 is its ability to selectively regulate the survival status of senescent cells. Under the influence of continuous metabolism, oxidative stress, and environmental stimuli, cells may gradually enter a state of senescence-associated arrest. These senescent cells undergo metabolic shifts and continuously release signaling factors that alter the surrounding microenvironment, thereby affecting the normal physiological activities of neighboring cells. FOXO4 precisely intervenes in intracellular protein interactions, disrupting the molecular links that sustain senescent cell survival; this triggers programmed apoptosis in these cells, thereby reducing their accumulation within the system. Throughout this regulatory process, the peptide has minimal impact on healthy cells, enabling selective modulation. Many similar bioactive agents struggle to distinguish between senescent and normal cells, often causing widespread cell loss and introducing unwanted experimental variables. In contrast, FOXO4 leverages its target-recognition specificity to act directly on senescence-related biochemical pathways while minimizing interference with healthy cells. This facilitates the construction of *in vitro* models for studying senescent cells and investigating their diverse effects on the microenvironment.
The maintenance of cellular homeostasis is a key area of research involving FOXO4. Various biochemical reactions within cells require the maintenance of dynamic equilibrium. The continuous accumulation of senescent cells disrupts the balance of the local microenvironment; the factors secreted by these cells trigger persistent stress responses and exacerbate cellular damage. By reducing the accumulation of senescent cells and lowering the release of senescence-associated factors, FOXO4 alleviates microenvironmental disruption and restores balance to the cellular population. This regulatory approach acts at the source; rather than merely inhibiting a single factor, it modulates the number of senescent cells to fundamentally curtail the continuous release of aberrant signals, allowing the microenvironment to gradually return to a stable state. In *in vitro* co-culture models, FOXO4 is frequently used to investigate how the senescence-associated microenvironment affects cell growth and differentiation, to explore the molecular mechanisms underlying cellular homeostasis, and to provide a reliable experimental tool for basic research into aging.
Antioxidant protection is a key mechanism by which FOXO4 maintains normal cellular physiology. Cellular metabolism constantly generates reactive oxygen species (ROS); their excessive accumulation damages intracellular nucleic acids and proteins, accelerates cellular injury, and drives cells into a state of senescence-associated arrest. FOXO4 regulates the expression of antioxidant genes, boosts intracellular antioxidant levels, and enhances the cell's capacity to scavenge reactive oxygen species. This mitigates the persistent damage caused by oxidative stress and delays the transition of healthy cells into a senescent state. A feedback loop exists between oxidative damage and cellular senescence: oxidative stress accelerates aging, while senescent cells further amplify local oxidative levels, creating a vicious cycle. FOXO4 intervenes in this cycle at two levels: it mitigates oxidative cellular damage and eliminates existing senescent cells—thereby blocking the spread of senescence signals—making it highly suitable for *in vitro* studies of stress-induced senescence.
FOXO4 is involved in regulating the cell cycle and programmed apoptosis pathways. Processes such as cell proliferation, quiescence, and programmed clearance are governed by a sophisticated molecular signaling network. Senescent cells permanently exit the cell cycle and cease proliferation, yet they fail to initiate normal clearance mechanisms, persisting within the system and releasing aberrant signals. FOXO4 acts on relevant protein interaction pathways to restore the apoptotic responsiveness of senescent cells, thereby facilitating their orderly programmed clearance. This regulatory mechanism does not indiscriminately trigger apoptosis in normal cells; instead, it specifically targets arrested, senescent cells, thereby maintaining the orderly cycling of the cell population. By utilizing FOXO4, researchers can delve into the molecular logic underlying cell cycle arrest and senescence evasion, elucidate how protein-protein interactions determine cell fate, and enrich fundamental theoretical research in the field of cellular senescence.
FOXO4 offers unique research value regarding the regulation of the extracellular matrix (ECM) microenvironment. The ECM serves as the structural environment essential for cell survival, maintaining a dynamic balance between the synthesis and degradation of matrix proteins. Senescent cells release large quantities of factors that disrupt this metabolic equilibrium, leading to the abnormal accumulation or excessive degradation of matrix components and compromising the environment required for cell adhesion and growth. By suppressing the secretion of senescence-associated factors, FOXO4 alleviates matrix metabolic disorders, restores the dynamic balance of matrix components, and optimizes the cellular microenvironment. This area represents the research frontier; a wealth of *in vitro* experiments continues to generate new data, expanding the scope of FOXO4’s scientific applications—including its use in establishing cell models for studying matrix aging.
Compared to other peptides that regulate cellular senescence, FOXO4’s greatest advantage lies in its unique mechanism of action. While many anti-aging peptides focus on cell protection and delaying the aging process—prioritizing prevention—FOXO4 targets established senescent cells for intervention, functioning as a clearance-oriented regulator. Some similar agents operate via broad pathways, simultaneously affecting multiple unrelated biochemical processes; this complexity complicates experimental variables and data analysis. In contrast, FOXO4 features an optimized molecular structure that targets specific protein interactions; its pathway of action is relatively clear, with fewer off-target effects and superior experimental reproducibility, making it ideal for research requiring precise investigation into senescence mechanisms. Furthermore, the solid-phase synthesis process for this peptide is well-established. Multi-stage purification techniques effectively remove impurities such as truncated fragments and synthesis by-products, ensuring minimal activity variation between production batches and meeting the stability requirements for long-term, continuous cell experiments.
Regarding physicochemical quality, FOXO4 is produced using mature solid-phase peptide synthesis technology and undergoes multi-step chromatographic purification to eliminate inactive impurities, resulting in a final product presented as a white lyophilized powder. The raw material features excellent water solubility; it dissolves rapidly in aqueous solvents to form a clear, precipitate-free solution, making it compatible with various cell culture media and aqueous experimental systems. Its lyophilized powder form effectively preserves the peptide's spatial conformation, minimizing activity loss during storage and transport. It retains biological activity over the long term under standard storage conditions and withstands long-distance cross-border shipping, meeting the procurement needs of laboratories worldwide.
FOXO4 offers significant potential for combination studies, allowing it to be paired with other active ingredients to establish complex cellular models. When combined with mitochondrial-protective peptides, it works synergistically to reduce oxidative damage and delay the aging of healthy cells. Pairing it with matrix-repairing peptides helps address matrix imbalances associated with aging, while combining it with homeostasis-regulating peptides enables simultaneous intervention in senescent cells and cellular protection, thereby simulating more complex and realistic biochemical environments. Such combination models facilitate the study of crosstalk between multiple pathways, broaden research dimensions, yield richer experimental data, and provide new insights into the multifaceted mechanisms of aging.
In scientific research, FOXO4 is primarily used in basic cell biology studies, including the exploration of mechanisms for identifying and clearing senescent cells, the construction of aging microenvironment models, oxidative stress-induced aging experiments, cell cycle regulation studies, and research on extracellular matrix aging. Extensive in vitro replication experiments have demonstrated FOXO4's stable activity, excellent reproducibility, and high data reliability, leading to its inclusion in the experimental reagent inventories of numerous university laboratories and biotech R&D institutions. As research into peptide molecular mechanisms advances, further potential regulatory effects of FOXO4 are being uncovered, continuously expanding its range of applications.
As the industry for peptide research reagents grows, research institutions are increasingly demanding materials for aging studies that offer high targeting specificity and clear mechanisms of action. Many anti-aging ingredients are limited in scope, offering only cellular protection without the ability to intervene in cells that have already become senescent. With its unique mechanism for targeting and regulating senescent cells, FOXO4 aligns perfectly with current research needs in the field of cellular aging. A mature, stable purification process ensures consistent supply and uniform batch activity, supporting long-term, continuous series of cellular experiments. Within the sector of peptides designed to regulate aging, FOXO4 continues to attract significant attention from researchers, with a growing body of literature and in vitro experimental findings emerging year by year.
Overall, FOXO4 is a targeted, synthetic bioactive peptide that achieves the precise regulation of senescent cells by modulating intracellular protein-protein interactions. It offers multiple benefits, including antioxidant protection, optimization of the cellular microenvironment, and the maintenance of cellular population homeostasis. The peptide exhibits stable physicochemical properties, excellent water solubility, high batch-to-batch consistency, and good compatibility in formulations, alongside specific and controllable biochemical effects. It is suitable for establishing various in vitro research models—such as those investigating cellular senescence, oxidative stress, and cell cycle regulation—thereby supporting fundamental research in cell biology. As advancements continue in peptide synthesis technology and the understanding of cellular senescence mechanisms, FOXO4 will remain a valuable asset in basic research, providing a stable and reliable experimental tool for studies on cellular physiological regulation.
TDS
United States
Germany
Russia
Canada
Norway
